956
Views
7
CrossRef citations to date
0
Altmetric
IMMUNE HEMATOLOGY

Expression of CD154 (CD40L) on stimulated T lymphocytes in patients with idopathic thrombocytopenic purpura

, , , &

Figures & data

Figure 1 CD154 expression on unstimulated CD4+T cells and stimulated CD4+T cells in representative normal control, non-immune thrombocytopenia patient, and idiopathic thrombocytopenic purpura (ITP) patient. Lymphocytes (A) were gated in a side scatter (SS)/CD45 fluorescence dot plot, and then CD4+T cells (B) within indicated lymphocytes were isolated. Histogram displayed fluorescence intensity of CD154 on the X axis and CD4+CD154+T cells (C) were analyzed.

Figure 1 CD154 expression on unstimulated CD4+T cells and stimulated CD4+T cells in representative normal control, non-immune thrombocytopenia patient, and idiopathic thrombocytopenic purpura (ITP) patient. Lymphocytes (A) were gated in a side scatter (SS)/CD45 fluorescence dot plot, and then CD4+T cells (B) within indicated lymphocytes were isolated. Histogram displayed fluorescence intensity of CD154 on the X axis and CD4+CD154+T cells (C) were analyzed.

Table 1 Characteristics of ITP patients and controls

Table 2 CD154 expression on CD4+T cells and serum soluble CD40 ligand in ITP patients and controls

Table 3 Correlation of platelet counts and serum soluble CD40 ligand with other parameters in ITP patients

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.